Preparation method of silk suture line based on enzymatic grafted chitosan oligosaccharide-protocatechuic acid
Through the preparation of enzymatic grafting of chin oligosaccharide-protocatechic acid modified silk sutures, the problems of insufficient strength and lack of antibacterial properties of existing sutures are solved, and efficient antibacterial performance and biocompatibility are achieved, suitable for high-quality high-quality sutures Tension wounds and medical applications.
Patent Information
- Application Number
- CN202411124798.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-16
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2044-08-16
AI Technical Summary
Existing medical sutures are insufficient in the face of high tension wounds, and some non-degradable fibers may cause wound redness and bacterial infection after use, and lack antibacterial and anti-inflammatory properties.
The preparation method of silk suture line modified by enzymatic grafting chitinoligosaccharide-protocatechic acid is used. After reacting with laccase, the silk fibers are grafted with silver nitrate, and silver nanoparticles are deposited with silver nitrate. , a silk suture line with antibacterial properties is formed.
It improves the antibacterial and mechanical properties of sutures, reduces the risk of wound infection, ensures biocompatibility and safety, and is suitable for the medical field.
Smart Images

Figure CN119020993A_ABST
Abstract
Description
Technical Field
[0001] The present application relates to the technical field of medical antibacterial textile materials, and in particular to a method for preparing a silk suture based on enzymatic grafting of chitosan oligosaccharide-protocatechuic acid. Background Art
[0002] As the application of textiles in the medical field continues to develop, the functional requirements for medical sutures are constantly increasing. An ideal suture should have good biocompatibility, mechanical properties, and the function of promoting wound healing. Silk, as a natural protein fiber, is extracted and processed to form silk sutures that are widely used. They have excellent biocompatibility, are not prone to inflammation and rejection reactions in the body, and have excellent knotting strength. However, after the wound is sutured, bacteria are prone to grow at the suture site, which in turn causes symptoms of bacterial infection. Attention should be paid to the anti-inflammatory properties of the suture. Therefore, silk sutures are modified to be antibacterial to reduce the risk of wound infection.
[0003] Chitosan oligosaccharide (COS) is a depolymerized polysaccharide product obtained by chemical and enzymatic hydrolysis of chitosan. COS has good water solubility, non-toxicity and biocompatibility, and has a wide range of biological activities, including antibacterial, anti-inflammatory, anti-obesity, neuroprotective, anti-cancer and antioxidant effects. It has antioxidant and antibacterial effects. The hydroxyl and amino activities in chitosan oligosaccharide are very active. The tyrosine residues in silk can be oxidized by the enzymatic action of laccase and then covalently coupled with chitosan oligosaccharide through Michael addition and Schiff base reaction.
[0004] Protocatechuic acid (PCA), also known as 3,4-dihydroxybenzoic acid, is a phenolic acid naturally present in many vegetables and fruits. It has an inhibitory effect on Staphylococcus aureus, Staphylococcus aureus, and Escherichia coli. Since some tyrosine residues in silk are difficult to be directly enzymatically grafted with chitosan oligosaccharides, in order to promote the grafting efficiency of chitosan oligosaccharides and silk fibers and improve the antibacterial properties of silk sutures, chitosan oligosaccharides are modified with protocatechuic acid and then enzymatically grafted, so that the amino group mediates the reduction of silver ions and stably deposits them on silk.
[0005] In the related art, some degradable sutures with short degradation cycles are disclosed, including polylactic acid sutures, collagen sutures, etc.; in addition, some sutures made of textile fibers such as medical polyester and medical silk that are high in strength but do not have antibacterial function are also disclosed.
[0006] However, the medical sutures in the related art have the following defects: some degradable sutures cannot reach the strength required to withstand wounds with relatively high tension, which limits the use of the product; in addition, some non-degradable sutures do not have certain biological activity and antibacterial and anti-inflammatory properties, and after use, they are likely to cause redness and swelling at the suture site of the wound, or even bacterial infection. Summary of the invention
[0007] The purpose of the present application is to provide a method for preparing silk sutures based on enzymatic grafting of chitosan oligosaccharide-protocatechuic acid to solve the problems existing in the above-mentioned prior art.
[0008] To achieve the above purpose, the technical solution adopted in this application is:
[0009] In a first aspect, the present application provides a method for preparing a silk suture based on enzymatic grafting of chitosan oligosaccharide-protocatechuic acid, the method comprising:
[0010] S1, modifying chitosan oligosaccharide by protocatechuic acid to obtain protocatechuic acid-modified chitosan oligosaccharide powder;
[0011] S2, preparing a solution of the protocatechuic acid-modified chitosan oligosaccharide powder and laccase, and then subjecting the solution to an enzymatic reaction with the degummed silk fiber to obtain enzymatically grafted silk fiber;
[0012] S3. In response to weaving the enzymatically grafted silk fibroin fibers into a silk braided thread, in-situ deposition of silver nanoparticles is performed using a silver nitrate solution to obtain a silk suture thread based on enzymatically grafted chitosan oligosaccharide-protocatechuic acid.
[0013] In a possible implementation, step S1 includes:
[0014] In response to protocatechuic acid being dissolved in ethanol, chitosan oligosaccharide being dissolved in buffer, 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride and N-hydroxysuccinimide being dissolved in buffer, the three solutions are mixed, dialyzed and freeze-dried to obtain protocatechuic acid-modified chitosan oligosaccharide powder.
[0015] In a possible implementation, the buffer is a PBS buffer prepared by dissolving potassium dihydrogen phosphate and disodium hydrogen phosphate dodecahydrate in deionized water, and the pH of the PBS buffer is 5.5.
[0016] In a possible implementation, the molar ratio of the potassium dihydrogen phosphate to the disodium hydrogen phosphate dodecahydrate is 25.54:1.
[0017] In a possible implementation, the molar ratio of the protocatechuic acid to the ethanol is 1:8.2.
[0018] In a possible implementation, the chitosan oligosaccharide and the buffer are prepared into a solution at a mass ratio of 2:25.
[0019] In a possible implementation, the molar ratio of the 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride to the N-hydroxysuccinimide is 1:2.
[0020] In a possible implementation, the mass ratio of the 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride, the N-hydroxysuccinimide, and the buffer is 199:239:1000.
[0021] In a possible implementation, step S1 includes:
[0022] In response to protocatechuic acid being dissolved in ethanol, chitosan oligosaccharide being dissolved in buffer, 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride and N-hydroxysuccinimide being dissolved in buffer, the three solutions are mixed at a volume ratio of 4:1:2 to obtain a first mixed solution;
[0023] The first mixed solution was stirred at room temperature for 12 hours, dialyzed using a dialysis membrane for three days, and then freeze-dried to obtain protocatechuic acid-modified chitosan oligosaccharide powder.
[0024] In a possible implementation, in the dialysate used for the dialysis, the volume ratio of deionized water to the first mixed solution is 100:1.
[0025] In a possible implementation, the molecular weight of the chitosan oligosaccharide is less than 2000.
[0026] In a possible implementation, the molecular structure of the protocatechuic acid is:
[0027]
[0028] In a possible implementation, step S2 includes:
[0029] The protocatechuic acid-modified chitosan oligosaccharide powder and laccase are prepared into a second mixed solution with concentrations of 1.5-2.0 g / L and 0.1-0.15 U / ml respectively by using a buffer solution, and then the degummed silk fiber and the second mixed solution are sealed at a liquid ratio of 20:1 to 30:1 and placed in a 50°C constant temperature water bath for reaction for 12-16 hours, then washed with deionized water for 3-5 times, and finally dried thoroughly at 40-50°C to obtain enzymatically grafted silk fiber.
[0030] In a possible implementation, the buffer is a PBS buffer prepared by dissolving potassium dihydrogen phosphate and disodium hydrogen phosphate dodecahydrate in deionized water, and the pH of the PBS buffer is 5.5.
[0031] In a possible implementation manner, the activity of the laccase is 0.5 U / mg.
[0032] In a possible implementation, the fineness of the degummed silk fiber is 75D.
[0033] In a possible implementation, step S3 includes:
[0034] Weaving the enzymatically grafted silk fibers into silk braided yarns on a braiding machine with 8 strands and an intercept of 2 mm;
[0035] The woven silk braided thread is placed in a prepared 0.8% silver nitrate solution, reacted in a sealed water bath at 70°C for 20 minutes, then washed with deionized water for 3-5 times, and finally dried at a constant temperature of 50°C to obtain a silk suture thread based on enzymatic grafted chitosan oligosaccharide-protocatechuic acid.
[0036] In a second aspect, the present application provides a silk suture based on enzymatic grafting of chitosan oligosaccharide-protocatechuic acid, wherein the silk suture is prepared by any of the above methods for preparing a silk suture based on enzymatic grafting of chitosan oligosaccharide-protocatechuic acid.
[0037] The beneficial effects of the technical solution provided by this application include at least:
[0038] 1. Based on the excellent biocompatibility of silk fiber, the natural antibacterial, anti-inflammatory and antioxidant properties of protocatechuic acid and chitosan oligosaccharide are utilized to enable the present application to have excellent antibacterial properties and applicability;
[0039] 2. Under the promotion of laccase, the grafting rate of silk fiber and chitosan oligosaccharide-protocatechuic acid was improved;
[0040] 3. Through the eight-strand braided structure, the mechanical properties of the antibacterial silk suture thread meet the requirements of the suture thread;
[0041] 4. A suture can be made on a medical braiding machine, which is convenient for process adjustment and has strong adjustability in thickness and length of the product;
[0042] 5. No toxic chemical reagents are used, which ensures human health and can be safely and widely used in medical, health and other fields. BRIEF DESCRIPTION OF THE DRAWINGS
[0043] The accompanying drawings are used to provide a further understanding of the present application and constitute a part of the specification. Together with the embodiments of the present application, they are used to explain the present application and do not constitute a limitation of the present application. In the accompanying drawings:
[0044] Figure 1 A flow chart showing a method for preparing a silk suture based on enzymatic grafting of chitosan oligosaccharide-protocatechuic acid provided by an exemplary embodiment of the present application is shown;
[0045] Figure 2 The Fourier near-infrared spectrum test graph of the protocatechuic acid-modified chitosan oligosaccharide powder and chitosan oligosaccharide provided in the specific embodiment 1 of the present application is shown;
[0046] Figure 3 The surface Zeta potential test diagram of the degummed silk fiber before and after grafting provided in the first specific embodiment of the present application is shown;
[0047] Figure 4 The schematic diagram of the enzymatic grafting mechanism provided in the first specific embodiment of the present application is shown;
[0048] Figure 5 The surface SEM image of the silk braided yarn provided in the first specific embodiment of the present application is shown;
[0049] Figure 6 The EDS graph (a) of Ag particle-deposited silk braided wire and the graph (b) of silver element content provided in the first specific embodiment of the present application are shown. DETAILED DESCRIPTION
[0050] The following will be combined with the drawings in the embodiments of the present application to clearly and completely describe the technical solutions in the embodiments of the present application. Obviously, the described embodiments are only part of the embodiments of the present application, not all of the embodiments. Based on the embodiments in the present application, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of this application.
[0051] Among them, the same parts are represented by the same figure marks. It should be noted that the words "front", "rear", "left", "right", "up" and "down" used in the following description refer to the directions in the drawings of the present application specification, and the words "bottom surface" and "top surface", "inside" and "outside" refer to the direction towards or away from a specific component, respectively. In addition, the terms "first" and "second" are used for descriptive purposes only and cannot be understood as indicating or implying relative importance or implicitly indicating the number of technical features indicated. Therefore, the features defined as "first" and "second" may explicitly or implicitly include one or more of the features. In the description of the present application specification, the meaning of "multiple" is two or more.
[0052] The present application is further described below in conjunction with the accompanying drawings and embodiments.
[0053] Figure 1 A flow chart of a method for preparing a silk suture based on enzymatic grafting of chitosan oligosaccharide-protocatechuic acid provided by an exemplary embodiment of the present application is shown, and the method comprises the following steps:
[0054] Step S1, modifying chitosan oligosaccharide with protocatechuic acid to obtain protocatechuic acid-modified chitosan oligosaccharide powder.
[0055] Specifically, step S1 comprises: in response to protocatechuic acid being dissolved in ethanol, chitosan oligosaccharide being dissolved in buffer solution, 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride and N-hydroxysuccinimide being dissolved in buffer solution, the three solutions are mixed, and after dialysis and freeze drying, protocatechuic acid modified chitosan oligosaccharide powder is obtained. The buffer solution is a PBS buffer solution prepared by dissolving potassium dihydrogen phosphate and disodium hydrogen phosphate dodecahydrate in deionized water, the pH of the PBS buffer solution is 5.5, and the molar ratio of potassium dihydrogen phosphate to disodium hydrogen phosphate dodecahydrate is 25.54:1
[0056] Furthermore, the molar ratio of the above-mentioned protocatechuic acid to ethanol is 1:8.2, and the solution is prepared by chitosan oligosaccharide and buffer solution in a mass ratio of 2:25; the molar ratio of the above-mentioned 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride to N-hydroxysuccinimide is 1:2; the mass ratio of the above-mentioned 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride, N-hydroxysuccinimide, and buffer solution is 199:239:1000.
[0057] Furthermore, the above step S1 includes: in response to protocatechuic acid being dissolved in ethanol, chitosan oligosaccharide being dissolved in buffer, 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride and N-hydroxysuccinimide being dissolved in buffer, the above three solutions are mixed in a volume ratio of 4:1:2 to obtain a first mixed solution; the first mixed solution is stirred at room temperature for 12 hours, dialyzed for three days using a dialysis membrane, and then freeze-dried to obtain protocatechuic acid-modified chitosan oligosaccharide powder. Wherein, in the dialysate used for dialysis: the volume ratio of deionized water to the first mixed solution is 100:1.
[0058] It should be noted that the molecular weight of chitosan oligosaccharide is less than 2000, and the molecular structure of protocatechuic acid is:
[0059]
[0060] Step S2: prepare a solution of protocatechuic acid-modified chitosan oligosaccharide powder and laccase, and then carry out an enzymatic reaction with the degummed silk fiber to obtain enzymatically grafted silk fiber.
[0061] Specifically, step S2 comprises: after preparing the protocatechuic acid-modified chitosan oligosaccharide powder and laccase into a second mixed solution with concentrations of 1.5-2.0 g / L and 0.1-0.15 U / ml respectively by a buffer, the degummed silk fiber and the second mixed solution are sealed in a 50° C. constant temperature water bath at a liquid ratio of 20:1 to 30:1 for reaction for 12-16 hours, then washed with deionized water for 3-5 times, and finally dried thoroughly at 40-50° C. to obtain enzymatic grafted silk fiber. The buffer is a PBS buffer prepared by dissolving potassium dihydrogen phosphate and disodium hydrogen phosphate dodecahydrate in deionized water, and the pH of the PBS buffer is 5.5.
[0062] Furthermore, the activity of laccase was 0.5 U / mg, and the fineness of the degummed silk fiber was 75D.
[0063] Step S3: in response to weaving the enzymatically grafted silk fibroin fibers into a silk braided thread, in-situ deposition of silver nanoparticles is performed using a silver nitrate solution to obtain a silk suture thread based on enzymatically grafted chitosan oligosaccharide-protocatechuic acid.
[0064] Specifically, step S3 includes: weaving the enzymatically grafted silk fibers into silk braided wires on a braiding machine with 8 strands and an intercept of 2 mm; placing the braided silk braided wires in a configured 0.8% silver nitrate solution, reacting them in a sealed water bath at 70°C for 20 minutes, then washing them with deionized water for 3-5 times, and finally drying them at a constant temperature of 50°C to obtain silk sutures based on enzymatically grafted chitosan oligosaccharide-protocatechuic acid.
[0065] It can be understood that a silk suture prepared by the above-mentioned method for preparing silk suture based on enzymatic grafting of oligochitosan-protocatechuic acid also falls within the scope of protection of the present application.
[0066] In order to better understand the present application, the present application is further described below in conjunction with the accompanying drawings and two specific embodiments. It should be noted that the embodiments described in the specific embodiments are only part of the embodiments of the present application and do not limit the scope of protection of the present application. Specific embodiment one:
[0068] A method for preparing a silk suture based on enzymatic grafting of chitosan oligosaccharide-protocatechuic acid, wherein the buffer used in the following method is the above-mentioned PBS buffer with a pH of 5.5, and the method comprises the following steps:
[0069] (1) Preparation and characterization of protocatechuic acid modified chitosan oligosaccharides:
[0070] 3.2 g of protocatechuic acid solid was placed in 10 ml of ethanol and slowly stirred with a glass rod to dissolve, to prepare solution A1;
[0071] Solution A2 was prepared by dissolving 3.2 g of chitosan oligosaccharide in 40 ml of PBS buffer;
[0072] Solution A3 was prepared by dissolving 3.98 g of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride and 4.78 g of N-hydroxysuccinimide in 20 ml of PBS buffer;
[0073] Solutions A1, A2, and A3 were mixed and stirred at room temperature for 12 h, and then dialyzed and freeze-dried to obtain protocatechuic acid-modified chitosan oligosaccharide powder;
[0074] In this example, the prepared protocatechuic acid modified chitosan oligosaccharide powder and chitosan oligosaccharide were tested by Fourier near infrared spectroscopy. The results are as follows: Figure 2 As shown, due to the addition of benzene ring groups after the modification of chitosan oligosaccharide with protocatechuic acid, the absorption peak of the characteristic functional group of protocatechuic acid appeared in the test curve of the chitosan oligosaccharide powder modified with protocatechuic acid, which shows that the modification reaction of the two is completed.
[0075] (2) Laccase-induced grafting of silk fiber with oligochitosan-protocatechuic acid:
[0076] The above-mentioned protocatechuic acid-modified chitosan oligosaccharide powder and laccase with an activity of 0.5U / mg were prepared into a mixed solution with concentrations of 2.0g / L and 0.15U / ml respectively using PBS buffer, and then the degummed silk fiber with a fineness of 75D and the mixed solution were sealed at a liquid ratio of 30:1 and placed in a 50℃ constant temperature water bath for reaction for 14h, then washed with deionized water 4 times, and finally dried thoroughly at 45℃ to obtain enzymatically grafted silk fiber.
[0077] In this example, untreated degummed silk fiber B1, degummed silk fiber directly mixed with protocatechuic acid-modified chitosan oligosaccharide powder B2, and degummed silk fiber grafted with protocatechuic acid-modified chitosan oligosaccharide powder under enzymatic conditions B3 were placed in the same amount of deionized water and sealed for 5 hours, and the supernatant was taken for 3 Zeta potential tests for each group. The test results are shown in Figure 2. Figure 3 As shown in the figure, due to the ionization of carboxyl groups in the degummed silk fibers, the untreated degummed silk fibers will be negatively charged above the isoelectric point. Since chitosan oligosaccharides are the only positively charged cationic alkaline amino oligosaccharides in nature, the higher Zeta potential of B3 indicates that under the action of laccase, more protocatechuic acid-modified chitosan oligosaccharide powder is grafted onto the surface of the degummed silk fibers. Figure 4 The figure shows a schematic diagram of the enzymatic grafting mechanism. Laccase hydroformylates the surface groups of the degummed silk fibers to increase the reaction activity.
[0078] (3) Preparation of silk sutures and deposition of silver nanoparticles:
[0079] The enzymatically grafted silk fibers are woven into silk braided threads on a braiding machine with 8 strands and an intercept of 2 mm. The braided silk braided threads are placed in a prepared 0.8% silver nitrate solution, reacted in a sealed water bath at 70°C for 20 minutes, then washed with deionized water for 4 times, and finally dried at a constant temperature of 50°C to obtain silk suture threads based on enzymatically grafted chitosan oligosaccharide-protocatechuic acid.
[0080] In this embodiment, the obtained silk suture based on enzymatic grafting of chitosan oligosaccharide-protocatechuic acid was subjected to surface electron microscopy analysis and surface element EDS test, such as Figure 5 As shown in FIG. 1 , after degumming, the silk fibers are woven to form a compact braided wire structure. Figure 6 As shown, the C, N, O, and Ag elements on the surface of the silk suture based on enzymatic grafting of oligochitosan-protocatechuic acid were tested. The surface Ag element was evenly distributed on the surface of the silk thread, and the content reached 2.8%, which has excellent antibacterial properties. Specific embodiment 2:
[0082] A method for preparing a silk suture based on enzymatic grafting of chitosan oligosaccharide-protocatechuic acid, wherein the buffer used in the following method is the above-mentioned PBS buffer with a pH of 5.5, and the method comprises the following steps:
[0083] (1) Preparation and characterization of protocatechuic acid modified chitosan oligosaccharides:
[0084] Place 1.6 g of protocatechuic acid solid in 5 ml of ethanol and slowly stir with a glass rod to dissolve, to prepare solution C1;
[0085] Solution C2 was prepared by dissolving 1.6 g of chitosan oligosaccharide in 20 ml of PBS buffer;
[0086] Solution C3 was prepared by dissolving 1.99 g of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride and 2.39 g of N-hydroxysuccinimide in 10 ml of PBS buffer;
[0087] Solutions C1, C2, and C3 were mixed and stirred at room temperature for 12 h, and then dialyzed and freeze-dried to obtain protocatechuic acid-modified chitosan oligosaccharide powder;
[0088] (2) Laccase-induced grafting of silk fiber with oligochitosan-protocatechuic acid:
[0089] The above-mentioned protocatechuic acid-modified chitosan oligosaccharide powder and laccase with an activity of 0.5U / mg were prepared into a mixed solution with concentrations of 1.5g / L and 0.1U / ml respectively using PBS buffer, and then the degummed silk fiber with a fineness of 75D and the mixed solution were sealed at a liquid ratio of 20:1 and placed in a 50℃ constant temperature water bath for reaction for 15h, then washed with deionized water for 5 times, and finally dried thoroughly at 45℃ to obtain enzymatically grafted silk fiber.
[0090] (3) Preparation of silk sutures and deposition of silver nanoparticles:
[0091] The enzymatically grafted silk fibers are woven into silk braided threads on a braiding machine with 8 strands and an intercept of 2 mm. The braided silk braided threads are placed in a prepared 0.8% silver nitrate solution, reacted in a sealed water bath at 70°C for 20 minutes, then washed with deionized water for 4 times, and finally dried at a constant temperature of 50°C to obtain silk suture threads based on enzymatically grafted chitosan oligosaccharide-protocatechuic acid.
[0092] Antimicrobial performance characterization:
[0093] The antibacterial test test method is in accordance with GB / T 20944.1-2007 "Evaluation of antibacterial properties of textiles Part 1: Agar plate diffusion method". The antibacterial properties of the modified silk braided wire prepared in the above-mentioned specific embodiment 1 and specific embodiment 2 are analyzed by the disk diffusion method. The bacteria are Staphylococcus aureus and Escherichia coli. The antibacterial efficiency of the silk suture wire enzymatically grafted with chitosan oligosaccharide-protocatechuic acid and nanosilver deposited is determined according to the GB / T 20944.3-2008 standard. It is calculated according to the formula: Antibacterial efficiency = [(N1-N2) / N1] × 100%, in which N1 is the bacterial colony count of the degummed silk fiber braided wire that has not been antibacterial modified; N2 is the bacterial colony count of the braided wire after degumming, silk fiber grafting modification and nanosilver deposition (i.e., the silk braided wire prepared in specific embodiment 1 and specific embodiment 2). The antibacterial rates of N1 and N2 were calculated by testing them without washing. Then, N1 and N2 were washed 10 times according to the GB / T 20944.1-2007 washing standard and then tested again to calculate the antibacterial rates.
[0094] The antibacterial test results of the silk braided wire prepared in the specific embodiment 1 are shown in Table 1 below:
[0095] Table 1:
[0096] Washing conditions Escherichia coli inhibition rate Staphylococcus aureus inhibition rate Unwashed 98.6% 99.3% Wash 10 times 80.4% 84.7%
[0097] The antibacterial test results of the silk braided wire prepared in the specific embodiment 2 are shown in Table 2 below:
[0098] Table 2:
[0099] Washing conditions Escherichia coli inhibition rate Staphylococcus aureus inhibition rate Unwashed 98.1% 98.9% Wash 10 times 81.6% 83.8%
[0100] It can be seen from Table 1 and Table 2 that the antibacterial properties of the braided wires prepared in Specific Embodiments 1 and 2 against both bacteria reached more than 98% when the number of washes was 0, and after 10 washes, the antibacterial rates against Escherichia coli and Staphylococcus aureus were still maintained at more than 80%. It can be concluded that the silk braided wire prepared in the present application has strong antibacterial properties.
[0101] The above is only a preferred implementation of the present application. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principles of the present application. These improvements and modifications should also be regarded as the scope of protection of the present application.
Claims
1. A method for preparing a silk suture based on enzymatic grafting of chitosan oligosaccharide-protocatechuic acid, characterized in that: The method comprises: S1, modifying chitosan oligosaccharide by protocatechuic acid to obtain protocatechuic acid-modified chitosan oligosaccharide powder; S2, preparing a solution of the protocatechuic acid-modified chitosan oligosaccharide powder and laccase, and then subjecting the solution to an enzymatic reaction with the degummed silk fiber to obtain enzymatically grafted silk fiber; S3. In response to weaving the enzymatically grafted silk fibroin fibers into a silk braided thread, in-situ deposition of silver nanoparticles is performed using a silver nitrate solution to obtain a silk suture thread based on enzymatically grafted chitosan oligosaccharide-protocatechuic acid.
2. The method for preparing silk suture based on enzymatic grafting of chitosan oligosaccharide-protocatechuic acid according to claim 1, characterized in that: The step S1 comprises: In response to protocatechuic acid being dissolved in ethanol, chitosan oligosaccharide being dissolved in buffer, 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride and N-hydroxysuccinimide being dissolved in buffer, the three solutions are mixed, dialyzed and freeze-dried to obtain protocatechuic acid-modified chitosan oligosaccharide powder.
3. The method for preparing silk suture based on enzymatic grafting of chitosan oligosaccharide-protocatechuic acid according to claim 2, characterized in that: The buffer solution is a PBS buffer solution prepared by dissolving potassium dihydrogen phosphate and disodium hydrogen phosphate dodecahydrate in deionized water, and the pH of the PBS buffer solution is 5.
5.
4. The method for preparing silk suture based on enzymatic grafting of chitosan oligosaccharide-protocatechuic acid according to claim 3, characterized in that: The molar ratio of the potassium dihydrogen phosphate to the disodium hydrogen phosphate dodecahydrate is 25.54:
1.
5. The method for preparing silk suture based on enzymatic grafting of chitosan oligosaccharide-protocatechuic acid according to claim 2, characterized in that: The molar ratio of the protocatechuic acid to the ethanol is 1:8.
2.
6. The method for preparing silk suture based on enzymatic grafting of chitosan oligosaccharide-protocatechuic acid according to claim 2, characterized in that: The chitosan oligosaccharide and the buffer solution are prepared at a mass ratio of 2:
25.
7. The method for preparing silk suture based on enzymatic grafting of chitosan oligosaccharide-protocatechuic acid according to claim 2, characterized in that: The molar ratio of the 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride to the N-hydroxysuccinimide is 1:
2.
8. The method for preparing silk suture based on enzymatic grafting of chitosan oligosaccharide-protocatechuic acid according to claim 2, characterized in that: The mass ratio of the 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride, the N-hydroxysuccinimide, and the buffer solution is 199:239:1000.
9. The method for preparing silk suture based on enzymatic grafting of chitosan oligosaccharide-protocatechuic acid according to claim 2, characterized in that: The step S1 comprises: In response to protocatechuic acid being dissolved in ethanol, chitosan oligosaccharide being dissolved in buffer, 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride and N-hydroxysuccinimide being dissolved in buffer, the three solutions are mixed at a volume ratio of 4:1:2 to obtain a first mixed solution; The first mixed solution was stirred at room temperature for 12 hours, dialyzed using a dialysis membrane for three days, and then freeze-dried to obtain protocatechuic acid-modified chitosan oligosaccharide powder.
10. The method for preparing silk suture based on enzymatic grafting of chitosan oligosaccharide-protocatechuic acid according to claim 9, characterized in that: In the dialysate used for the dialysis, the volume ratio of deionized water to the first mixed solution is 100:
1.
11. The method for preparing silk suture based on enzymatic grafting of chitosan oligosaccharide-protocatechuic acid according to claim 2, characterized in that: The molecular weight of the chitosan oligosaccharide is less than 2000.
12. The method for preparing silk suture based on enzymatic grafting of chitosan oligosaccharide-protocatechuic acid according to claim 2, characterized in that: The molecular structure of the protocatechuic acid is:
13. The method for preparing silk suture based on enzymatic grafting of chitosan oligosaccharide-protocatechuic acid according to claim 1, characterized in that: The step S2 comprises: The protocatechuic acid-modified chitosan oligosaccharide powder and laccase are prepared into a second mixed solution with concentrations of 1.5-2.0 g / L and 0.1-0.15 U / ml respectively by using a buffer solution, and then the degummed silk fiber and the second mixed solution are sealed at a liquid ratio of 20:1 to 30:1 and placed in a 50°C constant temperature water bath for reaction for 12-16 hours, then washed with deionized water for 3-5 times, and finally dried thoroughly at 40-50°C to obtain enzymatically grafted silk fiber.
14. The method for preparing silk suture based on enzymatic grafting of chitosan oligosaccharide-protocatechuic acid according to claim 13, characterized in that: The buffer solution is a PBS buffer solution prepared by dissolving potassium dihydrogen phosphate and disodium hydrogen phosphate dodecahydrate in deionized water, and the pH of the PBS buffer solution is 5.
5.
15. The method for preparing silk suture based on enzymatic grafting of chitosan oligosaccharide-protocatechuic acid according to claim 13, characterized in that: The activity of the laccase is 0.5 U / mg.
16. The method for preparing silk suture based on enzymatic grafting of chitosan oligosaccharide-protocatechuic acid according to claim 13, characterized in that: The fineness of the degummed silk fiber is 75D.
17. The method for preparing silk suture based on enzymatic grafting of chitosan oligosaccharide-protocatechuic acid according to claim 1, characterized in that: The step S3 comprises: Weaving the enzymatically grafted silk fibers into silk braided yarns on a braiding machine with 8 strands and an intercept of 2 mm; The woven silk braided thread is placed in a prepared 0.8% silver nitrate solution, reacted in a sealed water bath at 70°C for 20 minutes, then washed with deionized water for 3-5 times, and finally dried at a constant temperature of 50°C to obtain a silk suture thread based on enzymatic grafted chitosan oligosaccharide-protocatechuic acid.
18. A silk suture based on enzymatic grafting of chitosan oligosaccharide-protocatechuic acid, characterized in that: The silk suture is prepared by the preparation method of the silk suture based on enzymatic grafting of chitosan oligosaccharide-protocatechuic acid according to any one of claims 1 to 17.
Citation Information
Patent Citations
Antibacterial fibroin protein fiber and preparation method thereof
CN106835688A
Method for fibroin biomimetic mineralization based on enzymatic grafting / phosphorylation
CN107033366A
Method for carrying out antibacterial and antioxidant finishing on damask silk by enzyme method
CN111809394A
Natural long-acting antibacterial and anti-inflammatory silk suture line and production method thereof
CN114059350A
Catechol-grafted photosensitive chitosan oligosaccharide modified polyurethane film as well as preparation method and application thereof
CN116790002A
